Effect of combination therapy of metformin and fenofibrate on the hemostatic system in patients with impaired glucose tolerance

Effect of combination therapy of metformin and fenofibrate on the hemostatic system in patients with impaired glucose tolerance

Bibliographic Details
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2013-12-01
Series:	Ожирение и метаболизм
Online Access:	https://endojournals.ru/index.php/omet/article/view/6391

Similar Items

Metformin effects to carbohydrate and lipids metabolism in impaired glucose tolerance patients.
by: Alexander Vasil'evich Dreval', et al.
Published: (2010-06-01)

Comparison of Effectiveness and Safety of Add-on Therapy of Saroglitazar and Fenofibrate with Metformin in Indian Patients with Diabetic Dyslipidaemia
by: Arijit Ghosh, et al.
Published: (2016-03-01)

Comparative evaluation of metformin and liraglutide cardioprotective effect in rats with impaired glucose tolerance
by: Anna Simanenkova, et al.
Published: (2021-03-01)

Diabetic cardiomyopathy: effects of fenofibrate and metformin in an experimental model – the Zucker diabetic rat
by: Gadot Nicolas, et al.
Published: (2009-03-01)

PPARα Agonist Fenofibrate Reduced the Secreting Load of β-Cells in Hypertriglyceridemia Patients with Normal Glucose Tolerance
by: Jia Liu, et al.
Published: (2016-01-01)

Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy
by: Mariël F. van Stee, et al.
Published: (2018-06-01)

Fenofibrate Reverses Palmitate Induced Impairment in Glucose Uptake in Skeletal Muscle Cells by Preventing Cytosolic Ceramide Accumulation
by: Sudarshan Bhattacharjee, et al.
Published: (2015-10-01)

Impaired Secretion of Total Glucagon-like Peptide-1 in People with Impaired Fasting Glucose Combined Impaired Glucose Tolerance
by: Fang Zhang, Xialian Tang, Hongyi Cao, Qingguo Lü, Nali Li, Yupu Liu, Xiangxun Zhang, Yuwei Zhang, Mingming Cao, Jun Wan, Zhenmei An, Nanwei Tong
Published: (2012-01-01)

Diagnosis of Impairments in the Hemostatic System in the Use of Warfarin in Cardiac Surgical Patients
by: E. I. Goncharova, et al.
Published: (2015-09-01)

Evaluating efficacy and safety of differential therapy with atorvastatin, fenofibrate and their combination in patients with type 2 diabetes
by: G. A. Batrak
Published: (2015-12-01)

Real-World Effectiveness of Therapy With Rosuvastatin Combined With Fenofibric Acid in a Sample of Colombian Patients With Mixed Dyslipidemia
by: Manuel E. Machado-Duque, et al.
Published: (2020-11-01)

Transplantation and diabetes (Transdiab): a pilot randomised controlled trial of metformin in impaired glucose tolerance after kidney transplantation
by: Basil Alnasrallah, et al.
Published: (2019-04-01)

Sodium–glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin–metformin
by: Schwartz SS, et al.
Published: (2016-03-01)

Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes.
by: Anke Tönjes, et al.
Published: (2010-01-01)

Therapeutic potential of metformin in normal glucose tolerant persons with metabolic syndrome
by: Petya Kamenova
Published: (2020-01-01)

Fenofibrate plus Metformin Produces Cardioprotection in a Type 2 Diabetes and Acute Myocardial Infarction Model
by: Víctor Hugo Oidor-Chan, et al.
Published: (2016-01-01)

PROPHYLAXIS AND THERAPY OF IMPAIRED GLUCOSE TOLERANCE IN LONG-TERM THERAPY OF THE PATIENTS WITH SEVERE DERMATOSES WITH GLUCOCORTICOSTEROID HORMONES
by: Y. F. Kutasevych, et al.
Published: (2014-06-01)

Fenofibrate Protects Cardiomyocytes from Hypoxia/Reperfusion- and High Glucose-Induced Detrimental Effects
by: Fabiola Cortes-Lopez, et al.
Published: (2021-01-01)

Prevalence of impaired glucose tolerance in ischemic Egyptian patients
by: I.M. Attia, et al.
Published: (2013-12-01)

Effects of combined dietary supplementation with fenofibrate and Schisandrae Fructus pulp on lipid and glucose levels and liver function in normal and hypercholesterolemic mice
by: Zhu PL, et al.
Published: (2015-02-01)

Impaired glucose tolerance in sleep disorders.
by: Marietta Keckeis, et al.
Published: (2010-03-01)

Detection and treatment of impaired glucose tolerance
by: Page, Renee C. L.
Published: (1991)

Vascular function in impaired glucose tolerance : Effect of pioglitazone
by: Quinn, C. E.
Published: (2008)

Improved metabolic response after 16 weeks of calorie-restricted low-glycaemic index diet and metformin in impaired glucose tolerance subjects
by: Teresa Helena Macedo da Costa, et al.
Published: (2014-05-01)

Effect of repaglinide on endothelial dysfunction during a glucose tolerance test in subjects with impaired glucose tolerance
by: Wascher Thomas C, et al.
Published: (2006-04-01)

Efficacy and Safety of Fenofibrate in Patients with Hyperuricemia
by: Irfan Zafar, et al.
Published: (2012-04-01)

Fenofibrate/simvastatin fixed-dose combination in the treatment of mixed dyslipidemia: safety, efficacy, and place in therapy
by: Tarantino N, et al.
Published: (2017-02-01)

Amelioration of diet-induced steatohepatitis in mice following combined therapy with ASO-Fsp27 and fenofibrate
by: Ananthi Rajamoorthi, et al.
Published: (2017-11-01)

Effect of Fenofibrate in Patients with Type 2 Diabetic Nephropathy
by: Chen, Yihui, et al.
Published: (2013)

Perspectives of impaired glucose tolerance management in patients with metabolic syndrome
by: K. P. Ivanov, et al.
Published: (2011-08-01)

Lisinopril effects on platelet activity in patients with arterial hypertension and impaired glucose tolerance
by: I. N. Medvedev, et al.
Published: (2008-06-01)

Evaluation of Metformin on Cognitive Improvement in Patients With Non-dementia Vascular Cognitive Impairment and Abnormal Glucose Metabolism
by: Yufeng Lin, et al.
Published: (2018-07-01)

The Effect of Metformine on Glucose Control in Patients with Diabetes Type 1
by: Amir Ziaee, et al.
Published: (2010-09-01)

Associations of Fenofibrate Therapy With Incidence and Progression of CKD in Patients With Type 2 Diabetes
by: Rebecca Frazier, et al.
Published: (2019-01-01)

Evaluation of the hemostatic effect of a combination of hemostatic agents and fibrin glue in a rabbit venous hemorrhage model
by: Katsumi Takizawa, et al.
Published: (2021-07-01)

DIAGNOSIS AND THERAPY OF THE HEMOSTATIC SYSTEM DISORDERS IN LIVER TRANSPLANTATION
by: S. V. Zhuravel', et al.
Published: (2017-09-01)

STATE OF HEMOSTATIC SYSTEM IN SEPSIS PATIENTS
by: A. A. Аfanasiev, et al.
Published: (2018-07-01)

Combination of atorvastatin and fenofibrate altered androgenic activities of male rats
by: Kawa F. Dizaye, et al.
Published: (2019-08-01)

Comparison of efficacy and safety of choline fenofibrate (fenofibric acid) to micronized fenofibrate in patients of mixed dyslipidemia: A randomized, open-label, multicenter clinical trial in Indian population
by: Piyush Patel, et al.
Published: (2016-01-01)

Effect of metformin therapy on 2-h post-glucose insulin levels in patients of polycystic ovarian syndrome
by: Pikee Saxena, et al.
Published: (2010-01-01)

Cannot write session to /tmp/vufind_sessions/sess_j9k8fjsl15em3a8cnv1lngf81r